Patent · US Expired

Fusion glycoproteins

US5952474A · kind A · utility

21Cited by

3References

19Claims

0Family size

Assignee

The Public Health Research Institute Of the City of New York, Inc. · US

Inventors

Samuel Kayman · New York, US
Abraham Pinter · Brooklyn, US

Key dates

Filing date	Jul 1, 1997
Grant date	Sep 14, 1999
Priority date	—
Expiry date	Jul 1, 2017

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2810/6054
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Novel expression vectors are provided for expressing a fusion glycoprotein. The fusion glycoprotein contains the N-terminal globular domain of a retroviral env surface protein linked to a selected glycopeptide. Truncation glycoproteins as well as insertion glycoproteins are expressed using the vectors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.